Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
Clinical trial NCT05861128 · UNKNOWN
Trial details
- NCT number
- NCT05861128
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2025-12-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.